Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Neoplasms 5Breast Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Cardiovascular Diseases 2Triple Negative Breast Neoplasms 1Prostatic Intraepithelial Neoplasia 1Osteoporosis 1Neuralgia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Eye Diseases 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × Geritol × Clear all
NCT02050451 2017-03-29

Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy

Vanderbilt University Medical Center

Phase NA Completed
60 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00003623 2016-07-13

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
21 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡